These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 16213464)
1. Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma. O'Sullivan SE; Tarling EJ; Bennett AJ; Kendall DA; Randall MD Biochem Biophys Res Commun; 2005 Nov; 337(3):824-31. PubMed ID: 16213464 [TBL] [Abstract][Full Text] [Related]
2. Time-dependent vascular actions of cannabidiol in the rat aorta. O'Sullivan SE; Sun Y; Bennett AJ; Randall MD; Kendall DA Eur J Pharmacol; 2009 Jun; 612(1-3):61-8. PubMed ID: 19285060 [TBL] [Abstract][Full Text] [Related]
3. Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol. O'Sullivan SE; Kendall DA; Randall MD J Pharmacol Exp Ther; 2006 Apr; 317(1):428-38. PubMed ID: 16352700 [TBL] [Abstract][Full Text] [Related]
4. A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro. Whalley BJ; Wilkinson JD; Williamson EM; Constanti A Neurosci Lett; 2004 Jul; 365(1):58-63. PubMed ID: 15234473 [TBL] [Abstract][Full Text] [Related]
5. A role for p53 in the regulation of lysosomal permeability by delta 9-tetrahydrocannabinol in rat cortical neurones: implications for neurodegeneration. Gowran A; Campbell VA J Neurochem; 2008 May; 105(4):1513-24. PubMed ID: 18248609 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation. Zhao Y; Foryst-Ludwig A; Bruemmer D; Culman J; Bader M; Unger T; Kintscher U J Neurochem; 2005 Sep; 94(5):1395-401. PubMed ID: 15992368 [TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions. Suzuki T; Hayashi S; Miki Y; Nakamura Y; Moriya T; Sugawara A; Ishida T; Ohuchi N; Sasano H Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291 [TBL] [Abstract][Full Text] [Related]
8. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. O'Sullivan SE; Kendall DA; Randall MD Eur J Pharmacol; 2005 Jan; 507(1-3):211-21. PubMed ID: 15659311 [TBL] [Abstract][Full Text] [Related]
9. Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen. Bernardo A; Ajmone-Cat MA; Gasparini L; Ongini E; Minghetti L J Neurochem; 2005 Feb; 92(4):895-903. PubMed ID: 15686492 [TBL] [Abstract][Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells. Ogawa D; Nomiyama T; Nakamachi T; Heywood EB; Stone JF; Berger JP; Law RE; Bruemmer D Circ Res; 2006 Apr; 98(7):e50-9. PubMed ID: 16556873 [TBL] [Abstract][Full Text] [Related]
11. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells. Cheng Y; Ping J; Xu LM Chin Med J (Engl); 2007 May; 120(9):794-801. PubMed ID: 17531121 [TBL] [Abstract][Full Text] [Related]
13. Synthetic peroxisome proliferator-activated receptor-gamma agonists restore impaired vasorelaxation via ATP-sensitive K+ channels by high glucose. Kinoshita H; Azma T; Iranami H; Nakahata K; Kimoto Y; Dojo M; Yuge O; Hatano Y J Pharmacol Exp Ther; 2006 Jul; 318(1):312-8. PubMed ID: 16574781 [TBL] [Abstract][Full Text] [Related]
14. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. Lin MS; Chen WC; Bai X; Wang YD J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820 [TBL] [Abstract][Full Text] [Related]
15. Bacillus Calmette-Guérin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells. Lodillinsky C; Umerez MS; Jasnis MA; Casabé A; Sandes E; Eiján AM Int J Mol Med; 2006 Feb; 17(2):269-73. PubMed ID: 16391825 [TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide. Sommer M; Wolf G Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750 [TBL] [Abstract][Full Text] [Related]
17. Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells. Ceni E; Crabb DW; Foschi M; Mello T; Tarocchi M; Patussi V; Moraldi L; Moretti R; Milani S; Surrenti C; Galli A Gastroenterology; 2006 Oct; 131(4):1235-52. PubMed ID: 17030193 [TBL] [Abstract][Full Text] [Related]
18. Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Khare M; Taylor AH; Konje JC; Bell SC Mol Hum Reprod; 2006 May; 12(5):321-33. PubMed ID: 16597638 [TBL] [Abstract][Full Text] [Related]
19. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase. Liu CQ; Leung FP; Wong SL; Wong WT; Lau CW; Lu L; Yao X; Yao T; Huang Y Biochem Pharmacol; 2009 Aug; 78(4):374-81. PubMed ID: 19409373 [TBL] [Abstract][Full Text] [Related]
20. Rhodanine derivatives as novel peroxisome proliferator-activated receptor gamma agonists. Liu Q; Zhang YY; Lu HL; Li QY; Zhou CH; Wang MW Acta Pharmacol Sin; 2007 Dec; 28(12):2033-9. PubMed ID: 18031620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]